12 Health Care Stocks Moving In Monday's Intraday Session

Benzinga·06/01/2026 17:06:21

Listen to the news

Gainers

AIM ImmunoTech (AMEX:AIM) shares rose 126.8% to $0.93 during Monday's regular session. The company's market cap stands at $5.9 million.
Genenta Science (NASDAQ:GNTA) shares increased by 74.74% to $1.8. The market value of their outstanding shares is at $24.1 million.
Turn Therapeutics (NASDAQ:TTRX) stock moved upwards by 26.34% to $6.57. The company's market cap stands at $154.8 million.
Conexeu Sciences (NASDAQ:CNXU) shares rose 26.31% to $14.81. The company's market cap stands at $245.2 million.
HeartSciences (NASDAQ:HSCS) shares rose 25.74% to $2.1. The market value of their outstanding shares is at $5.3 million.
Outlook Therapeutics (NASDAQ:OTLK) shares rose 21.93% to $0.89. The company's market cap stands at $108.4 million.

Losers

PRF Technologies (NASDAQ:PRFX) shares declined by 35.0% to $1.95 during Monday's regular session. The market value of their outstanding shares is at $2.6 million.
Oculis Holding (NASDAQ:OCS) stock decreased by 34.87% to $14.79. The company's market cap stands at $1.3 billion.
NextCure (NASDAQ:NXTC) stock fell 30.63% to $4.3. The company's market cap stands at $22.3 million.
Co-Diagnostics (NASDAQ:CODX) shares declined by 28.61% to $6.09. The company's market cap stands at $31.4 million.
Akanda (NASDAQ:AKAN) shares decreased by 26.06% to $16.26. The company's market cap stands at $11.7 million.
Immuneering (NASDAQ:IMRX) stock fell 24.1% to $4.38. The market value of their outstanding shares is at $373.3 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

FAQ

Fee Schedule Open Account Deposit & Withdrawal Trading

Terms & Conditions

Client Agreement Privacy Policy Data Disclaimer Security Tips

About Webull

About us Webull Promotions Contact information Announcements

Contact Number :+852 3852 8500

Monday 7:00 AM - Saturday 9:00 AM (HKT)

Service Email :service@webull.hk

Online Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)

Business Cooperation :marketinghk@webull.hk

Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.

Language

English